Randomized, Crossover, Pharmacokinetic Study Of Paclitaxel (Taxol) And ABI-007 (A Cremophor EL-Free, Protein Stabilized, Nanoparticle Paclitaxel) In Patients With Advanced Solid Tumors
Latest Information Update: 03 Nov 2021
Price :
$35 *
At a glance
- Drugs Paclitaxel (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- 01 Apr 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
- 01 Apr 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
- 01 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.